GB0507552D0 - Methods and compounds for the treatment of cognitive dysfunction - Google Patents

Methods and compounds for the treatment of cognitive dysfunction

Info

Publication number
GB0507552D0
GB0507552D0 GBGB0507552.8A GB0507552A GB0507552D0 GB 0507552 D0 GB0507552 D0 GB 0507552D0 GB 0507552 A GB0507552 A GB 0507552A GB 0507552 D0 GB0507552 D0 GB 0507552D0
Authority
GB
United Kingdom
Prior art keywords
compounds
treatment
methods
cognitive dysfunction
cognitive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0507552.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FELLOWS AND SCHOLARS OF
College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Original Assignee
FELLOWS AND SCHOLARS OF
College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FELLOWS AND SCHOLARS OF, College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin filed Critical FELLOWS AND SCHOLARS OF
Priority to GBGB0507552.8A priority Critical patent/GB0507552D0/en
Publication of GB0507552D0 publication Critical patent/GB0507552D0/en
Priority to PCT/IE2006/000031 priority patent/WO2006109284A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0507552.8A 2005-04-14 2005-04-14 Methods and compounds for the treatment of cognitive dysfunction Ceased GB0507552D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0507552.8A GB0507552D0 (en) 2005-04-14 2005-04-14 Methods and compounds for the treatment of cognitive dysfunction
PCT/IE2006/000031 WO2006109284A1 (en) 2005-04-14 2006-04-18 Use of filamentous hemagglutinin for the treatment of cognitive dysfunction and neurodegenerative disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0507552.8A GB0507552D0 (en) 2005-04-14 2005-04-14 Methods and compounds for the treatment of cognitive dysfunction

Publications (1)

Publication Number Publication Date
GB0507552D0 true GB0507552D0 (en) 2005-05-18

Family

ID=34611121

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0507552.8A Ceased GB0507552D0 (en) 2005-04-14 2005-04-14 Methods and compounds for the treatment of cognitive dysfunction

Country Status (2)

Country Link
GB (1) GB0507552D0 (en)
WO (1) WO2006109284A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE128628T1 (en) * 1990-08-13 1995-10-15 American Cyanamid Co FIBER HEMAGGLUTININ FROM BORDETELLA PERTUSSIS AS A CARRIER FOR CONJUGATE VACCINE.
US5932217A (en) * 1991-05-03 1999-08-03 The Rockefeller University Peptides which inhibit adhesion between leukocytes and endothelial cells

Also Published As

Publication number Publication date
WO2006109284A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
IL190913A0 (en) Methods for the treatment of hyperhidrosis
IL179508A0 (en) 2-substituted-4- heteroaryl-pyrimidines useful for the treatment of proliferative disorders
EP1968583A4 (en) Compounds, screens, and methods of treatment
IL185016A0 (en) Compounds for the treatment of proliferative disorders
ZA200709727B (en) Compounds and methods for the treatment of prevention of flavivirus infections
IL191554A0 (en) Lactam compounds and methods of using the same
EP1744751A4 (en) Methods for the treatment of synucleinopathies
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
EP1809265A4 (en) Methods for the treatment of synucleinopathies
IL182436A0 (en) Thienopyridinone compounds and methods of treatment
IL185309A0 (en) Isoqunoline compounds and methods of use thereof
HK1117780A1 (en) Compounds and methods for the treatment of cancer
IL188728A0 (en) Methods of treating epileptogenesis
ZA200708033B (en) Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
EP1732549A4 (en) Methods for the treatment of synucleinopathies
IL187405A0 (en) Methods and compositions for the treatment of pain
EP2007790A4 (en) Compounds and methods for the treatment of pain
GB0517387D0 (en) Combinations for the treatment of cancer
HK1097247A1 (en) Process for the treatment of sludge
ZA200804872B (en) Lactam compounds and methods of using the same
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
EP1793813A4 (en) Treatment of adhd
IL226363A0 (en) Compounds and methods for the treatment of cancer
GB0426196D0 (en) Methods of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)